In a clear sign of the extreme degree of market lather over all companies related to the coronavirus situation, GeoVax Labs (OTCQB:GOVX), hoping to cash in on the buying frenzy, announces that it has signed a letter-of-intent with Wuhan-based vaccine developer BravoVax to jointly develop a vaccine against 2019-nCoV.
It says it will use its MVA-VLP platform and
know-how to design and construct the candidate using genetic sequences
from the current outbreak. BravoVax will be responsible for further
development and interactions with regulatory authorities.
https://seekingalpha.com/news/3534736-geovax-jumps-on-coronavirus-bandwagon-vaccine-announcement
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.